Human Molecular Genetics Advance Access published online on August 29, 2007
Human Molecular Genetics, doi:10.1093/hmg/ddm232
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adaptor protein Disabled-2 modulates low density lipoprotein (LDL) receptor synthesis in fibroblasts from patients with autosomal recessive hypercholesterolemia
MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, DuCane Road, London W12 ONN
* Corresponding author: Anne K Soutar, tel; +44 (0) 208 383 2324, fax: +44 (0) 208 383 2077, email: anne.soutar{at}csc.mrc.ac.uk
Received July 5, 2007; Revised August 19, 2007; Accepted August 19, 2007
Autosomal recessive hypercholesterolaemia (ARH), characterised clinically by severe inherited hypercholesterolaemia, is caused by recessive null mutations in LDLRAP1 (formerly ARH). Immortalised lymphocytes and monocyte-macrophages, and presumably hepatocytes, from ARH patients fail to take up and degrade plasma low density lipoproteins (LDL) because they lack LDLRAP1 protein, a cargo-specific adaptor required for clathrin-mediated endocytosis of the LDL receptor. Surprisingly, LDL-receptor function is normal in ARH patients' skin fibroblasts in culture. Disabled-2 (Dab2) has been implicated previously in clathrin-mediated internalisation of LDL-receptor family members, and we show here that Dab2 is highly expressed in skin fibroblasts, but not in lymphocytes. SiRNA-depletion of Dab2 profoundly reduced LDL-receptor activity in ARH fibroblasts as a result of profound reduction in LDL-receptor protein, but not mRNA; heterologous expression of murine Dab2 reversed this effect. In contrast, LDL-receptor protein content was unchanged in Dab-2 depleted control cells. Incorporation of 35S-labelled amino acids into LDL receptor protein revealed a corresponding apparent reduction in accumulation of newly-synthesised LDL-receptor protein on depletion of Dab2 in ARH, but not control, cells. This reduction in LDL-receptor protein in Dab2-depleted ARH cells could not be reversed by treatment of the cells with proteasomal or lysosomal inhibitors. Thus we propose a novel role for Dab2 in ARH fibroblasts, where it is apparently required to allow normal translation of LDL receptor mRNA.
1 Current Address: Cell Biology, Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL
2 The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. R. Thieman, S. K. Mishra, K. Ling, B. Doray, R. A. Anderson, and L. M. Traub Clathrin Regulates the Association of PIPKI{gamma}661 with the AP-2 Adaptor {beta}2 Appendage J. Biol. Chem., May 15, 2009; 284(20): 13924 - 13939. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Keyel, J. R. Thieman, R. Roth, E. Erkan, E. T. Everett, S. C. Watkins, J. E. Heuser, and L. M. Traub The AP-2 Adaptor {beta}2 Appendage Scaffolds Alternate Cargo Endocytosis Mol. Biol. Cell, December 1, 2008; 19(12): 5309 - 5326. [Abstract] [Full Text] [PDF] |
||||

